TGFBR1 Human

Transforming Growth Factor Beta Receptor I Human Recombinant
Cat. No.
BT221
Source

Sf9, Baculovirus cells.

Synonyms

TGFBR1, AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1, LDS1A, LDS2A, MSSE, SKR4, tbetaR-I, TGFR-1.

Appearance
Sterile filtered colorless solution.
Purity

Greater than 90.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TGFBR1produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 342 amino acids (27-126a.a.) and having a molecular mass of 38.0kDa. (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).
TGFBR1is expressed with a 242 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction

Transforming growth factor beta receptor 1 (TGFBR1) is a single-pass transmembrane protein belonging to the TGF-beta receptor subfamily and the protein kinase superfamily. This secreted protein is involved in a wide range of cellular processes, including the regulation of cell growth, differentiation, proliferation, and programmed cell death (apoptosis). TGFBR1 also plays a role in immune system modulation and exhibits varying effects on different cell types or cells at different developmental stages.

Description

Produced in Sf9 insect cells using a baculovirus expression system, this recombinant TGFBR1 protein is a single, glycosylated polypeptide chain consisting of 342 amino acids (27-126a.a.). It has a molecular weight of 38.0 kDa, although it may appear between 40-57 kDa on SDS-PAGE due to glycosylation. This protein is expressed with a 242 amino acid hIgG-His tag at the C-terminus and purified using proprietary chromatographic techniques.

Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation

The TGFBR1 protein is supplied as a 0.5 mg/mL solution in phosphate-buffered saline (PBS) at pH 7.4 containing 10% glycerol.

Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. The addition of a carrier protein such as 0.1% HSA or BSA is recommended for long-term storage. Repeated freezing and thawing of the product should be avoided.
Purity

The purity of this protein is greater than 90.0% as determined by SDS-PAGE analysis.

Synonyms

TGFBR1, AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1, LDS1A, LDS2A, MSSE, SKR4, tbetaR-I, TGFR-1.

Source

Sf9, Baculovirus cells.

Amino Acid Sequence

ADLLLPGATA LQCFCHLCTK DNFTCVTDGL CFVSVTETTD KVIHNSMCIA EIDLIPRDRP FVCAPSSKTG SVTTTYCCNQ DHCNKIELPT TVKSSPGLGP VELVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGKHHHH HH.

Product Science Overview

Definition and Classification

Transforming Growth Factor Beta Receptor I (TGFBR1), also known as Activin Receptor-Like Kinase 5 (ALK-5), is a serine/threonine kinase receptor that belongs to the protein kinase superfamily and the TGF-beta receptor subfamily . It is a single-pass type I membrane protein that plays a crucial role in the TGF-beta signaling pathway .

Biological Properties

TGFBR1 is expressed in all tissues examined, with the highest abundance in the placenta and the lowest in the brain and heart . The receptor is involved in various cellular processes, including cell growth, differentiation, apoptosis, and immune responses .

Expression Patterns and Tissue Distribution

TGFBR1 is ubiquitously expressed across different tissues. Its expression is particularly high in the placenta, indicating its significant role in reproductive and developmental processes . The receptor’s expression is relatively lower in the brain and heart .

Biological Functions

TGFBR1 functions as a tumor suppressor by inhibiting the cell cycle in the G1 phase . It is involved in the regulation of cellular growth, differentiation, apoptosis, motility, invasion, extracellular matrix production, angiogenesis, and immune responses . The receptor forms a complex with type II TGF-beta receptors upon ligand binding, leading to the phosphorylation and activation of SMAD transcriptional regulators .

Modes of Action

Upon ligand binding, TGFBR1 forms a receptor complex consisting of two type I and two type II transmembrane serine/threonine kinases . The type II receptors phosphorylate and activate the type I receptors, which then auto-phosphorylate and bind to SMAD proteins . This activation leads to the translocation of SMAD proteins to the nucleus, where they regulate the transcription of target genes .

Regulatory Mechanisms

The TGF-beta/SMAD pathway is tightly regulated to ensure proper cellular responses. Disruption of this pathway has been implicated in various human cancers, with the majority of colon and gastric cancers being caused by inactivating mutations in TGF-beta RII . The administration of TGF-beta has been shown to protect against mammary tumor development in transgenic mouse models .

Recombinant Human TGFBR1

Recombinant human TGFBR1 is produced using baculovirus expression systems in insect cells . The recombinant protein is often tagged with GST (Glutathione S-transferase) to facilitate purification and detection . It is supplied in a buffer containing Tris-HCl, NaCl, glutathione, EDTA, DTT, PMSF, and glycerol to maintain stability and activity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.